Speakers

David Sheehan

President & Chief Executive Officer • Nucleus Biologics

Dave was previously at Volcano Corporation a publicly held life sciences company that was sold to Philips for $1.2 Billion. Dave held various roles including the COO, EVP Global Operations and General Manager Volcano Japan, and President of several business units.  Prior to Volcano, Dave was the President and CEO of Digirad a medical imaging company he took public in 2004.  Prior to that, Dave worked at Baxter and Haemonetics.  He has extensive experience in product creation, manufacturing scale up, managing growth and organization development. Dave earned a BSME with Distinction from WPI and an MBA from The Amos Tuck School at Dartmouth College.

Also Speaking

Peter Olagunju

Chief Operating Officer • TCR2 Therapeutics

Alaina Schlinker

Senior Manager, Field Application Support Team • ScaleReady

Lili Belcastro

Senior Principal Scientist, Cell and Gene Therapy Raw Materials • Bristol Myers Squibb

Also Speaking

Image

2025 Downloadable Agenda

Download the post-event report for Advanced Therapies Week 2024.
Image

Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.